Outlaw Human Gene Patents: An Evening With Breast Cancer Action

joannloulanBy JoAnn Loulan, BCAction supporter and living with breast cancer

Sue Silber, Nancy Polikoff, Joan E. Biren (JEB), and I invite you to join us for a special evening of women’s health activism.

The U.S. Supreme Court will hear oral arguments in the landmark case challenging Myriad Genetics’ right to patent human genes on April 15th. Join us that evening for a special chance to get the inside scoop about the case and what happened during the oral arguments from Sandra Park, ACLU Senior Staff Attorney, Women’s Rights Project and Karuna Jaggar, Breast Cancer Action’ s Executive Director.

April 15th 7-9pm
Eatonville Restaurant – Enjoy Dessert and Drinks!
2121 14th St NW
Washington, DC 20009

$50 per person – Reserve your ticket today!

Myriad Genetics currently owns a patent on the “breast cancer genes” BRCA 1 and 2. Corporate ownership of our genes harms women’s health and blocks progress on breast cancer research. Learn what BCAction and the ACLU are doing to stop this biotech company from blocking breast cancer research, setting exorbitant prices for genetic testing, and harming women’s health.

BCAction is the only breast cancer organization that is a plaintiff in this lawsuit challenging a corporation’s right to patent our genes.

Be sure to bring your friends for this special opportunity to meet with the women’s health activists leading the charge against human gene patents and we hope you’ll be inspired to support the work of Breast Cancer Action at the end of the evening.

P.S. I hope you can join us earlier that day for a rally to outlaw human gene patents on the steps of the Supreme Court!

This entry was posted in BCA Action Alerts, BCA Events, BCA News, E-Alerts.